(4mo); 2,3,4,5,6‐pentafluorobenzyl (f5); benzyl (b); and methyl (m)); X = Cl and Br; R′ = benzyl (b) and methyl (m); and X′ = Cl and I. From these salts, heteroleptic Ir(III) complexes containing one N‐heterocyclic carbene (NHC) ligand [Ir(κ2‐ppy)2(κ2‐(pm‐Rb))]PF6 (R = 4f, 1(PF6); 3f, 2(PF6); 2f, 3(PF6); f5b, 4(PF6); 4c, 5(PF6); 3c, 6(PF6); 2c, 7(PF6); 4mo, 8(PF6); b, 9(PF6); m, 10(PF6)) and [Ir(κ2‐p
所述有机盐的1-(2-
吡啶基甲基)-3- alkylbenzimidazolium卤化物(PM-RBH + X - )和1-(2-
吡啶基甲基)-3-烷基
咪唑鎓卤化物(PM-R'iH + X' - )中制备(其中R = 4-,3-,2-
氟苄基(分别为4f,3f和2f),4-,3-,2-
氯苄基(分别为4c,3c和2c); 4-甲氧基苄基(4mo);
2,3,4,5,6-五氟苄基(f 5);苄基(b);甲基(m)); X = Cl和Br; R'=苄基(b)和甲基(m); X'= Cl和I。从这些盐中,杂合的Ir(III)配合物含有一个N-杂环卡宾(NHC)
配体的[Ir(κ 2 -ppy)2(κ 2 - (PM-RB))] PF 6(R = 4F,1(PF 6);图3F中,2(PF 6); 2F,3(PF 6); f 5 b,4(PF 6); 4c,5(PF 6); 3c,6(PF 6); 2c,7(PF